In This Section
Department of Pharmaceutical and Healthcare Business
Our expert faculty not only understand pharmaceutical and healthcare business—they work on the frontlines, sharing their firsthand knowledge with students, establishing new insights into the field, and forging connections in the profession. If you want to succeed in the expanding and evolving industry of healthcare, you need to understand the business of it. Attain that unique advantage at USciences, and launch a career that stand outs in a competitive job market.
|Our BS in pharmaceutical and healthcare business and MBA in pharmaceutical and healthcare business programs are accredited by the Accreditation Council for Business Schools and Programs (ACBSP), a leading specialized accreditation association for business education supporting, celebrating, and rewarding teaching excellence.|
- Loading Events...
Watch USciences 197th Commencement Live on May 23
May 18, 2018
We will be streaming USciences 197th Commencement Ceremony live on May 23 at 1 p.m.
USciences' MBA Program Again Ranked Among Elite Programs
April 13, 2018
University of the Sciences' MBA in Pharmaceutical and Healthcare Business continues to be ranked among the top tier programs in North America offering the degree.
2018 USciences Graduate Fellows Celebrated
April 11, 2018
Graduate students and their advisors celebrated the students' academic and research accomplishments at the annual graduate fellows reception on April 9, 2018.
USciences Announces College Restructuring for 2018-19
February 21, 2018
The main element of the restructure is the elimination of Mayes College of Healthcare Business and Policy with its programs being repositioned to the other colleges.
USciences and Franklin BioScience, a Leading Medical Cannabis Innovator, Announce Collaboration
December 19, 2017
Agreement Builds on USciences excellence in research and education; leverages Franklin BioScience's expertise and knowledge of the cannabis plant and deep history of bringing innovative science-backed medical cannabis products to patients.
Robert Mueller, EdD
Interim Chair, Department of Pharmaceutical and Healthcare Business
4101 Woodland Avenue, Room 147
University of the Sciences
600 South 43rd Street
Philadelphia, PA 19104-4495